biliary cirrhosis


Also found in: Thesaurus, Medical, Encyclopedia.
Related to biliary cirrhosis: secondary biliary cirrhosis

biliary cirrhosis

n.
1. Cirrhosis of the liver caused by obstruction of the bile ducts.
References in periodicals archive ?
Bonnie was diagnosed with primary biliary cirrhosis in 2007.
This can cause liver damage and eventually lead to biliary cirrhosis and liver failure.
Bone disorders may be found in viral, autoimmune or alcoholic CLD, but more frequently in CLD associated with cholestasis such as primary biliary cirrhosis and primary sclerosing cholangitis (4)' (5).
Mrs Roberts was diagnosed with primary biliary cirrhosis - an autoimmune disease that tries to destroy the liver - in 1991, with a prognosis she would need a transplant within 15 years.
Primary Biliary Cirrhosis (PBC) is an idiopathic, cholestatic destruction of intra-hepatic microscopic bile ducts.
VERY ITCHY SKIN IF A patient is experiencing a distressing itch with no obvious skin cause, this can be a sign of primary biliary cholangitis (PBC), also known as primary biliary cirrhosis, an autoimmune disease of the liver.
If a patient is experiencing a distressing itch with no obvious skin cause, this can be a sign of primary biliary cholangitis, also known as primary biliary cirrhosis, an autoimmune disease of the liver.
4] Other rare causes of cirrhosis are Wilson's disease, Haemochromatosis, primary biliary cirrhosis, primary sclerosing cholangitis and Alpha-1-antitrypsin deficiency.
Ocaliva was granted accelerated approval for the treatment of primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA.
Common causes of intra hepatic cholestasis include viral, alcoholic and non-alcoholic hepatitisboth acute and chronic, primary biliary cirrhosis, medication induced, infiltrative diseases, pregnancy, sepsis and hypo perfusion states.
Biopharmaceutical company Intercept Pharmaceuticals (NasdaqGS:ICPT) said on Thursday that the US Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee has voted in favour of the accelerated approval of Ocaliva (obeticholic acid) for the treatment of primary biliary cirrhosis, also called primary biliary cholangitis (PBC), a rare chronic liver disease that typically progresses to hepatic fibrosis, cirrhosis, liver failure and death unless they receive a liver transplant.
The disease is a part of small biliary duct diseases and the major diseases affecting these ducts as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are to be ruled out before labeling IAD [3].